Robotic Hair Restoration for Male Pattern Baldness
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are actively using anti-coagulation medication.
What data supports the effectiveness of the treatment ARTAS System, ARTAS Robotic Hair Restoration, ARTAS iX for male pattern baldness?
How is the ARTAS System treatment different from other treatments for male pattern baldness?
The ARTAS System is unique because it uses a robotic technology to precisely harvest hair follicles from the donor area, which can lead to more accurate and consistent results compared to manual methods. This system analyzes images of the scalp and uses a specialized needle and punch to extract hair follicles, making it a novel approach in hair restoration.13678
What is the purpose of this trial?
Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.
Eligibility Criteria
This trial is for men aged 20 to 70 with male pattern baldness (Norwood-Hamilton grade III-VI). Participants must be willing to cut their hair short for the procedure and agree to follow-up appointments. Men who've had scalp reduction surgery in the last six months, have bleeding disorders, or are on blood thinners cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo follicular hair unit harvest, recipient site making, and implantation using the ARTAS System
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- ARTAS System
ARTAS System is already approved in United States, European Union for the following indications:
- Harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair
- Harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair
Find a Clinic Near You
Who Is Running the Clinical Trial?
Venus Concept
Lead Sponsor